HDAC5 expression was also elevated in estrogen-independent breast cancer cells and induced tamoxifen resistance via the miR-125a-5p/specificity protein 1 (Sp1)/survivin axis (53). The gene discussed is HDAC5; the disease is breast carcinoma.